ProCE Banner Events

A Treatment Option For Patients with ESR1-mutated, ER+/HER2- mBC Following Progression on Initial ET +/- a CDK4/6i

Join us to gain insights on a second line treatment in ESR1 mutated, ER+/HER2-mBC.

Key Takeaways:
- Understanding the need for ESR1 mutation testing at each progression, and how results can inform treatment options

This event has expired. No longer available for credits.

Time and location

Wednesday, July 31, 2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Acknowledgement

Sponsored By

Stemline